Jason M. Hafron, MD

Michigan Institute of Urology

Troy, Michigan

Jason M. Hafron, MD, is the Director of Research at the Michigan Institute of Urology, P.C. He is also an Associate Professor of Urology at the William Beaumont School of Medicine at Oakland University in Rochester, Michigan, and the Director of Robotic Surgery at Beaumont Hospital, Royal Oak. Dr. Hafron is experienced in all areas of adult urology, but specializes in the minimally invasive treatment of cancers involving the prostate, kidney, and bladder utilizing laparoscopic and robotic surgery. Dr. Hafron received his BS from the University of Michigan and his MD from Loyola University Chicago-Stritch School of Medicine. Dr. Hafron completed his General Surgery and Urology Residency at the Albert Einstein College of Medicine Montefiore Medical Center in New York City. He continued his training as a Fellow in Advanced Laparoscopic and Robotic Surgery at the Cleveland Clinic Foundation, Glickman Urological and Kidney Institute, in Cleveland, Ohio.

Dr. Hafron has published numerous peer-reviewed articles and has presented his work at national and international meetings. He is the principal investigator for multiple clinical research trials at the Michigan Institute of Urology. He is on the Board of Directors of the United Physicians Organization, and has been certified in urology by the American Board of Urology.

Disclosures:

Talks by Jason M. Hafron, MD

Implementing Changes in Patient Behavior

Posted by Jason M. Hafron, MD | Jun 2024

Jason M. Hafron, MD, provides guidance on implementing changes in ADT patient behavior and motivating compliance with lifestyle adjustments. He begins by reviewing the body composition changes which result from ADT.

Dr. Hafron discusses how these changes in body composition, along with other adverse effects of ADT, led to the creation of the Prostate Cancer 360 (PC36) Working Group. This interdisciplinary group developed monitoring and management recommendations intended to mitigate or prevent ADT-associated adverse events in a PC360 Handbook, which includes pre-ADT counseling on lifestyle changes.

He presents the benefits of different levels of physical exercise for patients on ADT. He examines data demonstrating the impact of standardized exercise on ADT patient QoL, noting that physical exercise has significant benefits.

Dr. Hafron concludes with guidance on patient nutrition. He notes that diet has a significant influence on prostate cancer survival rate, with a typical Western diet significantly increasing the mortality rate for patients on ADT.

What Makes Millennials Tick? Understanding the Young Urologist

Posted by Jason M. Hafron, MD | Jun 2019

Jason M. Hafron, MD, discusses the growing presence of millennials in the workplace, particularly in urologic practices. He emphasizes that millennial physicians’ have the ability to advance the urologic field by applying their talents and perspectives regarding technology, efficiency, and physician/patient relationships.